Navigation Links
Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents
Date:10/6/2009

NATICK, Mass., Oct. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its WallFlex(®) Biliary RX fully and partially covered stents for the palliative treatment of malignant bile duct strictures. The WallFlex Biliary RX uncovered stent was cleared by the FDA in 2006. All three models of the WallFlex Biliary RX Stenting System -- fully covered, partially covered and uncovered -- are now available in both the United States and Europe.

"The WallFlex Biliary RX Stent System represents the next stage in self-expandable metal stent technology. The stent has greater flexibility to aid with placement in tortuous anatomies and new features such as flared ends that may reduce the risk of migration," said Kenneth F. Binmoeller, M.D., Director of Interventional Endoscopy at California Pacific Medical Center, and an investigator for the WallFlex Biliary RX fully covered stent study.

The WallFlex Biliary RX Stent is designed to offer the benefits of prior-generation stents, such as the industry-leading WALLSTENT(®) Endoprosthesis, while incorporating new features to accommodate a range of anatomical and clinical requirements. Based on extensive research and physician feedback, the WallFlex Biliary RX Stent employs a platinum-cored Nitinol construction designed to deliver on three critical components: radial force, flexibility and radiopacity. The Platinol(TM) Wire provides greater flexibility - 30 percent more than the WALLSTENT Endoprosthesis - to help the stent conform within tortuous anatomies. The enhanced full-length radiopacity offered by the Platinol Wire and the reconstrainable delivery system are designed to allow for more precise stent placement, while the radial force of the WallFlex Bi
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
2. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
3. The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA -- Hynes Convention Center October 31 -- November 3, 2009
4. SPIRIT IV Results Reaffirm Strong Performance of Boston Scientific PROMUS(R) and TAXUS(R) Express(R) Stents
5. Boston Scientific Announces Schedule for European Society of Cardiology Congress
6. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
7. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
8. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
9. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
10. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
11. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014  Ambit Biosciences (Nasdaq: ... and development of drugs targeting unmet needs in oncology, ... second quarter operational results after closing of the NASDAQ ... A conference call hosted by Michael Martino ... management will take place on the same day at ...
(Date:7/29/2014)... July 29, 2014  Cloud Pharmaceuticals, Inc., a ... development, announced today that it has been awarded ... Foundation Small Business Innovation Research (NSF SBIR) program. ... Cloud Pharmaceuticals designs new drugs and drug ... new, innovative cloud computing technology in place of ...
(Date:7/29/2014)... 29, 2014 , Next ... development program has commenced , TPM®/Oxycodone Phase ... during Q4 2014 , TPM®/Oxymorphone Phase 2 ... 1H 2015 Australian drug delivery company, Phosphagenics ... transdermal patch programs after its recent announcement of a $19.2 million ...
Breaking Medicine Technology:Ambit Biosciences To Announce Second Quarter 2014 Financial Results 2Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000 2Phosphagenics Provides Update on Opioid Patch Program 2Phosphagenics Provides Update on Opioid Patch Program 3Phosphagenics Provides Update on Opioid Patch Program 4Phosphagenics Provides Update on Opioid Patch Program 5Phosphagenics Provides Update on Opioid Patch Program 6
... N.J., Jan. 6 Pacira Pharmaceuticals, Inc., an,acute ... been completed in two pivotal Phase III SIMPLE ... single intraoperative administration of EXPAREL(TM),(DepoBupivacaine) for prolonged postoperative ... the studies in hemorrhoidectomy and in total knee,arthroplasty ...
... Inc.,(Nasdaq: MITI ), a biopharmaceutical company developing ... autoimmune diseases,provides an outlook on key events anticipated for ... intends to provide an update on its research and ... -- April 12 to 16, 2009: Update on ...
Cached Medicine Technology:Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5
(Date:7/29/2014)... July 29, 2014 Bret Busacker ... ’s Boise office, has been appointed to the Board ... Idaho. , Busacker is an experienced business attorney with ... He advises clients on a wide spectrum of topics ... administration, compliance, and governance concerns. His clients include public ...
(Date:7/29/2014)... The report, “Heat Transfer Fluids Market by Type (Mineral ... Others), by Application (Oil & Gas, Chemical, CSP, Manufacturing ... Forecasts to 2019” defines and segments the global heat ... the global consumption in terms of volume and value. ... through 199 page sand in-depth TOC on"Heat Transfer Fluids ...
(Date:7/29/2014)... News) -- Quitting smoking is harder for people with ... make it more difficult to ride out the anxiety, cravings ... cold turkey, scientists found. But extra exercise -- even just ... "The review should be seen as a call to ... the department of exercise science at Concordia University in Montreal, ...
(Date:7/29/2014)... More Zeppelin than Zen, the Rock Spa® at ... having a complete renovation and, upon its re-opening in the ... and soul. , The Rock Spa® will include an all-new ... for experienced hair and nail stylists. Both part time and ... will be given full medical and health benefits, a rare ...
(Date:7/29/2014)... July 29, 2014 The report ... Cosmetics), Type (Rotary, Volumetric, Aseptic, Net Weight), Process ... Geography - Global Trend & Forecast to 2019”, ... into food, beverage, pharmaceutical, and cosmetic segments with ... each of these segments, in terms of value. ...
Breaking Medicine News(10 mins):Health News:Holland & Hart Partner Brett Busacker Appointed to Board of Directors for American Red Cross of Greater Idaho 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 3Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 4Health News: Extra Exercise Could Help Depressed Smokers Quit: Study 2Health News:Rock Spa® at Seminole Hard Rock Hotel & Casino Tampa Prepares for Expansion 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 3Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 4
... ... Announces Plans to Franchise Medical Marijuana Dispensaries in CA, Stock is ... are planning to franchise medical marijuana dispensaries compliant with state and ... (500%) in two days. For more complete coverage on the ...
... ... Products’ East Coast Distribution Center serves as a fulfillment center established to expedite the ... States. , ... ND (Vocus) May 14, 2010-- Swanson Health Products (SHP) is proud to announce ...
... ... study that shows vacations with animals will help the family bond. Spending quality time with the ... , ... and more families are finding it exciting and different to spend their vacations at a Dude ...
... , Two essays look at ethical issues arising from ... patients with severe brain injury might be able to ... Life , Authors: J. Andrew Billings, Larry R. Churchill, ... to consciousness or a meaningful existence? The authors ...
... ... quality and choice for its many customers who have been touched by cancer, CIGNA expands ... ... Recognizing the importance of access, quality and choice for its many customers who have been ...
... Simple blood test could spot those who need more ... -- Seventy percent of pregnant women in the United ... , What,s more, the regimen of prenatal vitamins that ... D to boost levels when needed, researchers from the ...
Cached Medicine News:Health News:Cannabis Medical Solutions Announces Plan to Franchise Ownership of Medical Marijuana Dispensaries in California 2Health News:Cannabis Medical Solutions Announces Plan to Franchise Ownership of Medical Marijuana Dispensaries in California 3Health News:Swanson Health Products Opens East Coast Distribution Center 2Health News:Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved 2Health News:Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved 3Health News:Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved 4Health News:The Hastings Center Report table of contents for May/June 2010 2Health News:The Hastings Center Report table of contents for May/June 2010 3Health News:CIGNA and Cancer Treatment Centers of America Reach New Agreement 2Health News:Many Pregnant Woman Not Getting Enough Vitamin D 2
Toothed Pituitary IVD Rongeurs, 8 length 200 mm....
Suitable for children and adults. New mechanical design of the skull pin holder and the clamp base ensures improved rigid skull fixation....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
... is designed for rigid skeletal ... greater freedom in positioning the ... skeletal fixation is designed for ... sitting positions. Craniotomies can be ...
Medicine Products: